Posts by Synthetic Biologics, Inc.
We are excited to announce positive topline safety and
We are excited to announce positive topline safety and tolerability results from our Phase 1a clinical trial of SYN-004, our first-in-class drug candi...
We are excited to announce positive topline safety and tolerability results from our Phase 1a clinical trial of SYN-004, our first-in-class drug candi...
During the week of November 17th, the CDC is observing “Get
During the week of November 17th, the CDC is observing “Get Smart About Antibiotics Week”. What might the first preventative therapy look like fo...
During the week of November 17th, the CDC is observing “Get Smart About Antibiotics Week”. What might the first preventative therapy look like fo...
Today we announced with FUJIFILM Diosynth Biotechnologies UK
Today we announced with FUJIFILM Diosynth Biotechnologies UK confirmation of exceptional results from the initial phase of cGMP manufacturing of SYN-0...
Today we announced with FUJIFILM Diosynth Biotechnologies UK confirmation of exceptional results from the initial phase of cGMP manufacturing of SYN-0...